Efficacy of resveratrol in patients with pre and first stage hypertensio

Not Applicable

• Conditions: Hypertension.; High Blood pressure; I10-I15

• Registration Number: IRCT201407078129N7
• Lead Sponsor: Deputy of Research, Bushehr University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Pre-hypertensive(average of two times measurement with an interval of 15 minutes, diastolic and systolic blood pressure(80-89mmHg, 120-139 mmHg respectively)
• Stage 1 hypertensive (average of two times measurement with an interval of 15 minutes (diastolic and systolic blood pressure 90-99 mmHg, 140-159 mmHg, respectively)
• Male or Female
• Age between 20 and 60-years
• Ability to provide informed consent

Exclusion Criteria

Approved or doubtful secondary hypertension; History of chronic or acute kidney Disease; History of heart failure; History of chronic or acute liver diseases; History of diabetes mellitus; History of prior cardiovascular events (Acute Myocardial Infarction, Cardiovascular diseases, Percutaneous Coronary Angioplasty or Coronary Artery Bypass Graft); Pregnancy or breast feeding;Blood arterial pressure >160/110

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Diastolic and systolic blood pressure. Timepoint: once in a week during intervention period. Method of measurement: A sphygmomanometer and Stethoscope will be used to measure the blood pressure, once in a week, and average of two times within 15 minutes will be recorded.;Added at 2015-04-16: Mean arterial pressure. Timepoint: Added at 2015-04-16: once in a week during intervention. Method of measurement: Added at 2015-04-16: systolic blood BP plus 2 times diastolic BP divided by 3.